Covid vaccine stock in Delhi will last for a day, claims official bulletin

The stock of anti-coronavirus vaccines in the national capital will last for a day only, claimed an official bulletin issued on Friday.

coronavirus, Covid-19, vaccination, vaccine
Press Trust of India New Delhi
1 min read Last Updated : Jul 16 2021 | 8:05 PM IST

The stock of anti-coronavirus vaccines in the national capital will last for a day only, claimed an official bulletin issued on Friday.

The city had administered 33,186 vaccine doses on Thursday of which 21,189 were first jabs and 11,997 second.

According to official data, the total number of vaccine doses administered in Delhi so far has reached 91,86,905.

On Friday morning, Delhi had 2,27,600 doses of Covaxin and 1,13,900 doses of Covishield in its balance stock. This was after 1,04,150 doses of Covishield were added to the stock on Thursday.

According to the Delhi government, since Covaxin stock is "limited and have irregular delivery cycle" only 20 per cent of it can be used for first dose.

The vaccination programme is running at 1,374 centres with a capacity of administering 2,26,552 vaccine doses daily.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :Coronavirus VaccineDelhiVaccination

First Published: Jul 16 2021 | 8:05 PM IST

Next Story